Home > Insider Trading > Filing (0000891839-18-000122)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1205922	Vaccinex Inc.	VCNX	Pharmaceutical Preparations (2834)	161603202

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1747756	E. Scott Royer	C/O Vaccinex, Inc. 1895 Mount Hope Avenue Rochester NY 14620	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-27	311	$4.15	311	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock option (right to buy)	$13.60		2028-02-21	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2028-02-21	25,000	25,000	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.20. The reporting person undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number or shares purchased at each separate price.
This option initially vests in quarterly installments of 1,526 shares for each of four quarters beginning on May 21, 2018. The remainder vests in three equal annual installments beginning February 21, 2020.